DK1001944T3 - Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser - Google Patents

Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser

Info

Publication number
DK1001944T3
DK1001944T3 DK98939676T DK98939676T DK1001944T3 DK 1001944 T3 DK1001944 T3 DK 1001944T3 DK 98939676 T DK98939676 T DK 98939676T DK 98939676 T DK98939676 T DK 98939676T DK 1001944 T3 DK1001944 T3 DK 1001944T3
Authority
DK
Denmark
Prior art keywords
ch2oh
alk
choh
equal
preparation
Prior art date
Application number
DK98939676T
Other languages
Danish (da)
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1001944T3 publication Critical patent/DK1001944T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98939676T 1997-07-17 1998-07-15 Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser DK1001944T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709058A FR2766187B1 (fr) 1997-07-17 1997-07-17 Derives de pyrazine, leur preparation et les medicaments les contenant
PCT/FR1998/001542 WO1999003844A1 (fr) 1997-07-17 1998-07-15 Derives de pyrazine, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
DK1001944T3 true DK1001944T3 (da) 2004-02-09

Family

ID=9509300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939676T DK1001944T3 (da) 1997-07-17 1998-07-15 Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser

Country Status (24)

Country Link
US (1) US6399613B1 (ko)
EP (1) EP1001944B1 (ko)
JP (1) JP4443036B2 (ko)
KR (1) KR20010021901A (ko)
CN (1) CN1264371A (ko)
AT (1) ATE251144T1 (ko)
AU (1) AU747127B2 (ko)
BR (1) BR9810880A (ko)
CA (1) CA2296727C (ko)
DE (1) DE69818679T2 (ko)
DK (1) DK1001944T3 (ko)
ES (1) ES2205536T3 (ko)
FR (1) FR2766187B1 (ko)
HU (1) HUP0004602A3 (ko)
IL (1) IL134040A0 (ko)
MX (1) MXPA00000280A (ko)
NO (1) NO20000198D0 (ko)
NZ (1) NZ501906A (ko)
PL (1) PL338148A1 (ko)
PT (1) PT1001944E (ko)
RU (1) RU2194703C2 (ko)
SK (1) SK482000A3 (ko)
WO (1) WO1999003844A1 (ko)
ZA (1) ZA986337B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905771D0 (en) * 1999-03-12 1999-05-05 Isis Innovation Compounds
US7598278B2 (en) * 2002-04-11 2009-10-06 L'oreal Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
US20080015197A1 (en) * 2006-06-26 2008-01-17 Alex Mainfeld Process for the preparatrion of zopiclone
US20080287447A1 (en) * 2007-01-31 2008-11-20 Nina Finkelstein Methods for preparing eszopiclone
CN101891679B (zh) * 2009-05-19 2014-04-16 上海华明高技术(集团)有限公司 吡啶二甲酸与二氨基吡啶质子转移化合物的制备方法
FR3030248B1 (fr) 2014-12-22 2018-03-23 L'oreal Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220650A (en) * 1978-10-18 1980-09-02 Pfizer Inc. Organic diamine therapeutic compositions and methods
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
JPH01117863A (ja) * 1987-10-30 1989-05-10 Toyobo Co Ltd 新規なアミド化合物
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
FR2766187A1 (fr) 1999-01-22
HUP0004602A2 (hu) 2001-11-28
MXPA00000280A (es) 2002-04-17
IL134040A0 (en) 2001-04-30
DE69818679T2 (de) 2004-07-29
PT1001944E (pt) 2004-02-27
ATE251144T1 (de) 2003-10-15
NO20000198L (no) 2000-01-14
CA2296727C (fr) 2009-06-09
HUP0004602A3 (en) 2001-12-28
KR20010021901A (ko) 2001-03-15
RU2194703C2 (ru) 2002-12-20
CN1264371A (zh) 2000-08-23
JP2001510188A (ja) 2001-07-31
NZ501906A (en) 2002-04-26
JP4443036B2 (ja) 2010-03-31
FR2766187B1 (fr) 2000-06-02
ES2205536T3 (es) 2004-05-01
US6399613B1 (en) 2002-06-04
AU8810298A (en) 1999-02-10
NO20000198D0 (no) 2000-01-14
EP1001944B1 (fr) 2003-10-01
PL338148A1 (en) 2000-09-25
CA2296727A1 (fr) 1999-01-28
EP1001944A1 (fr) 2000-05-24
ZA986337B (en) 1999-01-27
AU747127B2 (en) 2002-05-09
SK482000A3 (en) 2000-06-12
BR9810880A (pt) 2002-05-21
WO1999003844A1 (fr) 1999-01-28
DE69818679D1 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
DK0641767T3 (da) Cytotoksiske stilbenderivater og farmaceutisk præparat indeholdende disse derivater
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
HK1022639A1 (en) New use for 1,3-propanediol derivatives.
FI840635A (fi) Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel.
ATE109763T1 (de) Benzophenon-derivate.
SE7706392L (sv) N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning
DK1001944T3 (da) Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
ES8506979A1 (es) Procedimiento para preparar nuevas sales de alquil (cadena larga) amonio de n-fosfonometilglicina
BG105123A (en) Tetrahydroquinaline derivatives as glycine antagonists
HUP9900088A2 (hu) Pirimidinszármazékok, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
FI810632L (fi) 5,6:8,9-tetrahydro-7h-dibenz (d f)azoninderivat deras framstaellning och foereningar innehaollande dem
DK1001943T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
BG101942A (en) Analogues of arginine having inhibiting activity on no-synthetase
DE3864336D1 (en) Aromatische thioaether.
ES2059685T3 (es) Acilaminoalquilpiridinamidas inhibidoras de metastasis tumoral.
ES2061864T3 (es) Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene.
ES8506035A1 (es) Procedimiento para preparar nuevas sales de bis-alquilfosfonico de n-fosfonometilglicina